691 related articles for article (PubMed ID: 16863928)
1. External beam radiation therapy followed by high-dose-rate brachytherapy for inoperable superficial esophageal carcinoma.
Pasquier D; Mirabel X; Adenis A; Rezvoy N; Hecquet G; Fournier C; Coche-Dequeant B; Prevost B; Castelain B; Lartigau E
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1456-61. PubMed ID: 16863928
[TBL] [Abstract][Full Text] [Related]
2. A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): final report.
Gaspar LE; Winter K; Kocha WI; Coia LR; Herskovic A; Graham M
Cancer; 2000 Mar; 88(5):988-95. PubMed ID: 10699886
[TBL] [Abstract][Full Text] [Related]
3. [The multimodality therapy of advanced inoperable esophageal carcinoma. A retrospective analysis].
Mücke R; Ziegler PG; Libera T; Klautke G; Fietkau R
Strahlenther Onkol; 2000 Aug; 176(8):350-5. PubMed ID: 10987017
[TBL] [Abstract][Full Text] [Related]
4. External beam radiation therapy with or without high-dose-rate intraluminal brachytherapy for patients with superficial esophageal carcinoma.
Nishimura Y; Okuno Y; Ono K; Mitsumori M; Nagata Y; Hiraoka M
Cancer; 1999 Jul; 86(2):220-8. PubMed ID: 10421257
[TBL] [Abstract][Full Text] [Related]
5. Radiation therapy alone for stage I (UICC T1N0M0) squamous cell carcinoma of the esophagus: indications for surgery or combined chemoradiotherapy.
Ishikawa H; Sakurai H; Tamaki Y; Nonaka T; Yamakawa M; Saito Y; Kitamoto Y; Higuchi K; Hasegawa M; Nakano T
J Gastroenterol Hepatol; 2006 Aug; 21(8):1290-6. PubMed ID: 16872312
[TBL] [Abstract][Full Text] [Related]
6. Is extended volume external beam radiation therapy covering the anastomotic site beneficial in post-esophagectomy high risk patients?
Yu E; Dar R; Rodrigues GB; Stitt L; Videtic GM; Truong P; Tomiak A; Ash R; Brecevic E; Inculet R; Malthaner R; Vincent M; Craig I; Kocha W; Lefcoe M
Radiother Oncol; 2004 Nov; 73(2):141-8. PubMed ID: 15542160
[TBL] [Abstract][Full Text] [Related]
7. [Curative treatment of non-metastatic esophageal cancer: concomitant chemoradiotherapy and high-dose-rate endoluminal curietherapy boost].
Taieb S; Vaillant E; Pommier P; Bonvoisin S; Desseigne F; Morignat E; Gerard JP; Mornex F
Gastroenterol Clin Biol; 1999 Oct; 23(10):1048-54. PubMed ID: 10592877
[TBL] [Abstract][Full Text] [Related]
8. Three-year results of treatment for prostate cancer with low-dose rate temporary iridium-192 brachytherapy.
Momma T; Saito S; Toya K; Yorozu A; Dokiya T; Murai M
Int J Urol; 2006 Mar; 13(3):218-23. PubMed ID: 16643612
[TBL] [Abstract][Full Text] [Related]
9. Long-term results of definitive radiotherapy for stage I esophageal cancer.
Sai H; Mitsumori M; Araki N; Mizowaki T; Nagata Y; Nishimura Y; Hiraoka M
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1339-44. PubMed ID: 16029790
[TBL] [Abstract][Full Text] [Related]
10. Comparison of low and high dose rate brachytherapy in the treatment of uterine cervix cancer. Retrospective analysis of two sequential series.
Ferrigno R; Nishimoto IN; Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1108-16. PubMed ID: 15990016
[TBL] [Abstract][Full Text] [Related]
11. Hypoxic versus normoxic external-beam irradiation of cervical carcinoma combined with californium-252 neutron brachytherapy. Comparative treatment results of a 5-year randomized study.
Tacev T; Vacek A; Ptácková B; Strnad V
Strahlenther Onkol; 2005 May; 181(5):273-84. PubMed ID: 15900423
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic outcome and prognostic factors in the radiotherapy of recurrences of cervical carcinoma following surgery.
Hille A; Weiss E; Hess CF
Strahlenther Onkol; 2003 Nov; 179(11):742-7. PubMed ID: 14605743
[TBL] [Abstract][Full Text] [Related]
13. High-dose-rate brachytherapy in uterine cervical carcinoma.
Patel FD; Rai B; Mallick I; Sharma SC
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):125-30. PubMed ID: 15850912
[TBL] [Abstract][Full Text] [Related]
14. Esophageal cancer. A prospective phase II study of concomitant-boost external-beam chemoradiation with a top-up endoluminal boost.
Brunner TB; Rupp A; Melzner W; Grabenbauer GG; Sauer R
Strahlenther Onkol; 2008 Jan; 184(1):15-22. PubMed ID: 18188518
[TBL] [Abstract][Full Text] [Related]
15. The safety and usefulness of high-dose-rate endoluminal brachytherapy as a boost in the treatment of patients with esophageal cancer with external beam radiation with or without chemotherapy.
Vuong T; Szego P; David M; Evans M; Parent J; Mayrand S; Corns R; Burtin P; Faria S; Devic S
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):758-64. PubMed ID: 16199311
[TBL] [Abstract][Full Text] [Related]
16. Swallowing function and weight change observed in a phase I/II study of external-beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 9207).
Gaspar LE; Winter K; Kocha WI; Pinover WH; Herskovic ; Graham M; Gunderson L
Cancer J; 2001; 7(5):388-94. PubMed ID: 11693897
[TBL] [Abstract][Full Text] [Related]
17. External beam and intraluminal radiotherapy in the treatment of carcinoma of the esophagus.
Hyden EC; Langholz B; Tilden T; Lam K; Luxton G; Astrahan M; Jepson J; Petrovich Z
J Thorac Cardiovasc Surg; 1988 Aug; 96(2):237-41. PubMed ID: 3398546
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors for patients with esophageal cancer treated with radiation therapy in PCS: a preliminary study.
Tanisada K; Teshima T; Ikeda H; Abe M; Yamashita T; Nishio M; Inoue T; Hiraoka M; Hirokawa Y; Oguchi M; Yamada S; Sakai K; Nishimura T; Chatani M
Radiat Med; 1998; 16(6):461-8. PubMed ID: 9929147
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of locally advanced esophageal cancer by combined intralumenal brachytherapy and external beam radiotherapy].
Mileusnić D; Durbaba M; Vucićević S; Stanković J; RadosevićJelić Lj; Pekmezović T
Srp Arh Celok Lek; 1995; 123(9-10):254-7. PubMed ID: 17974443
[TBL] [Abstract][Full Text] [Related]
20. The role of radiation therapy after incomplete resection of penile cancer.
Langsenlehner T; Mayer R; Quehenberger F; Prettenhofer U; Langsenlehner U; Pummer K; Kapp KS
Strahlenther Onkol; 2008 Jul; 184(7):359-63. PubMed ID: 19016034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]